Intranasal Oxytocin and Enhancement of Team Cohesion
Status:
Completed
Trial end date:
2019-05-31
Target enrollment:
Participant gender:
Summary
This study attempts to identify the psychological, behavioral, physiological, and hormonal
predictors and mechanisms of an individual's ability to develop cohesion in a group working
together as a team; and examine if administration of the prosocial neuropeptide oxytocin
enhances the development of team cohesion. Through a deeper understanding of the underlying
psychobiological predictors and mechanisms of team cohesion, the prospective identification
of individuals whose unique characteristics promote or inhibit the development of group
cohesion will become possible.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
San Francisco Veterans Affairs Medical Center United States Department of Defense